Upadacitinib

Brands

Rinvoq

Upadacitinib Extended Release Oral Tablet

DosageBrandImage
24 HR upadacitinib 15 MG Extended Release Oral TabletGeneric
24 HR upadacitinib 15 MG Extended Release Oral Tablet [Rinvoq]Generic

Upadacitinib desired effects:

  • Increased Extracellular Communication

Upadacitinib pharmacologic actions:

  • Antirheumatic Agents
  • Janus Kinase Inhibitors

Upadacitinib mechanism of action:

  • Janus Kinase Inhibitors
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Questions? Call or text: 859-651-7603

LegitScript approved
Copyright © Treatable 2023
Last updated: 4/17/2024, 4:25:12 AM